Showing results (81-90 of 135) with videos related to
Sort By:
Pageof 14
Viruses|August 29, 2024
Modeling the Dynamic of Multiwave Diseases: The Model of Hand, Foot and Mouth DiseasePatrice Ravel, Nghia Ngu Duy, Guilhem Kister, et al.The Journal of Experimental Medicine|November 17, 2010
CD14 is a coreceptor of Toll-like receptors 7 and 9Christoph L Baumann, Irene M Aspalter, Omar Sharif, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patientsOlivier Adotevi, Helene Pere, Patrice Ravel, et al.European Journal of Immunology|February 14, 2015
The RNA-binding protein HuR/ELAVL1 regulates IFN-β mRNA abundance and the type I IFN responseBarbara Herdy, Thomas Karonitsch, Gregory I Vladimer, et al.Plos One|October 17, 2013
A target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLUwe Rix, Jacques Colinge, Katharina Blatt, et al.Nature Chemical Biology|October 2, 2012
Systems-pharmacology dissection of a drug synergy in imatinib-resistant CMLGeorg E Winter, Uwe Rix, Scott M Carlson, et al.Nature Immunology|June 7, 2011
IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNAAndreas Pichlmair, Caroline Lassnig, Carol-Ann Eberle, et al.Breast Cancer Research : BCR|October 22, 2008
A candidate molecular signature associated with tamoxifen failure in primary breast cancerJulie A Vendrell, Katherine E Robertson, Patrice Ravel, et al.Genome Biology|August 2, 2013
Experimental characterization of the human non-sequence-specific nucleic acid interactomeGerhard Dürnberger, Tilmann Bürckstümmer, Kilian Huber, et al.Scientific Reports|March 12, 2021
MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesisDiala Kantar, Emilie Bousquet Mur, Maicol Mancini, et al.Pageof 14